Enzymatic action of phospholipase A₂ on liposomal drug delivery systems

Anders H Hansen1, Ole G Mouritsen1, Ahmad Arouri1

  • 1MEMPHYS-Center for Biomembrane Physics, Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark; The Lundbeck Foundation Nanomedicine Research Center for Cancer Stem Cell Targeting Therapeutics (NanoCAN), University of Southern Denmark, Odense, Denmark.

Insights

Secretory phospholipase A2 (sPLA2) enzyme activity on liposomes is sensitive to lipid composition and temperature, impacting drug delivery. Understanding these factors optimizes sPLA2-triggered liposomal drug release in tumors.

Area of Science:

  • Biochemistry
  • Materials Science
  • Drug Delivery

Background:

  • Overexpression of secretory phospholipase A2 (sPLA2) in tumors enables enzyme-triggered drug carrier unloading.
  • Liposome composition, drug loading, and tumor microenvironment effects on sPLA2 activity require further investigation for targeted drug delivery.

Purpose of the Study:

  • To physico-chemically characterize sPLA2-assisted liposome breakdown for drug delivery.
  • To investigate the influence of temperature, lipid concentration, enzyme concentration, and drug loading on liposome hydrolysis.
  • To assess sPLA2 sensitivity to liposome composition, including lipid acyl-chain length and surface charge.

Main Methods:

  • Utilized dye-release assays to study liposome breakdown under physiologically relevant conditions.
  • Investigated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) liposomes with snake venom sPLA2.
  • Examined binary lipid mixtures of phosphatidylcholine (PC) and phosphatidylglycerol (PG) with varying acyl chains (C14, C16).

Main Results:

  • Increased temperature (36-41°C) primarily reduced enzyme lag-time, with minor effects on lipid hydrolysis rate.
  • Enzyme lag-time showed an inverse dependency on the lipid-to-enzyme ratio.
  • Drug encapsulation altered liposome hydrolysis profiles.
  • Human sPLA2 activity was highly sensitive to phospholipid acyl-chain length and liposome surface charge density.

Conclusions:

  • Physico-chemical parameters significantly influence sPLA2-mediated liposome hydrolysis.
  • Findings provide a basis for optimizing sPLA2-susceptible liposomal formulations for targeted cancer therapy.
  • This research aids in predicting liposome hydrolysis in vivo for improved drug delivery efficacy.

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
Asymmetric Lipid Bilayer01:35

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
11.1K
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
4.4K
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
126
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.2K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.6K